Search - tctmd.com

Displaying 141 - 160 of 183

Sort: Relevancy | Date

Presentation TVT 2016

The Sentinel US Pivotal Clinical Trial Design

Presenter: Susheel Kodali

June 17, 2016

Presentation TVT 2016

The Sentinel Dual Filter Device: Design Features and EU Clinical Trial Results

Presenter: Nicolas M. Van Mieghem

June 17, 2016

Presentation TVT 2016

Access Site Management Strategies, Including New Large-Hole Closure Devices - 2

Presenter: Alexandre Abizaid

June 17, 2016

Presentation TVT 2016

Access Site Management Strategies, Including New Large-Hole Closure Devices - 1

Presenter: Nicolas M. Van Mieghem

June 17, 2016

Presentation TVT 2016

The Bard TRUE Balloon: Design Features and Clinical Applications

Presenter: Jeffrey J. Popma

June 17, 2016

Presentation TVT 2016

The InterValve V8 Balloon: Design Features and Clinical Applications

Presenter: Wesley R. Pedersen

June 17, 2016

Presentation TVT 2016

STATE-OF-THE-ART LECTURE: Balloon Aortic Valvuloplasty in 2016 Equipment, Optimal Procedural Techniques, and Clinical Outcomes

Presenter: Helene Eltchaninoff

June 17, 2016

News Conference News TVT 2016

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Shelley Wood

June 17, 2016

News Conference News TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Michael O'Riordan

June 16, 2016

News Daily News

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

Yael L. Maxwell

May 02, 2016

News Daily News

A-fib Post-TAVR Associated With Increased Risk of Mortality, Bleeding

Michael O'Riordan

April 18, 2016

News Daily News

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Michael O'Riordan

March 14, 2016

News Daily News

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

Shelley Wood

February 23, 2016

News Daily News

Post-TAVR Myocardial Injury Linked to Mortality

Caitlin E. Cox

November 02, 2015

News Industry News

Medeon Biodesign Announces Successful First-in-man Studies for Large Bore Vascular Closure Device

November 02, 2015

News Industry News

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

October 15, 2015

News Daily News

A-fib, Whether Preexisting or New-Onset, Tied to Poor Outcomes in TAVR

Yael L. Maxwell

August 30, 2015

News Daily News

Chronic Pacing Linked to Lower Survival After Balloon-Expandable TAVR

August 20, 2015

News Daily News

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Todd Neale

July 27, 2015

News Industry News

Essential Medical Inc. Announces Successful Commencement of EU Studies for MANTA™ Large Bore Vascular Closure Device

July 27, 2015

Advertisement

The Sentinel US Pivotal Clinical Trial Design

The Sentinel Dual Filter Device: Design Features and EU Clinical Trial Results

Access Site Management Strategies, Including New Large-Hole Closure Devices - 2

Access Site Management Strategies, Including New Large-Hole Closure Devices - 1

The Bard TRUE Balloon: Design Features and Clinical Applications

The InterValve V8 Balloon: Design Features and Clinical Applications

STATE-OF-THE-ART LECTURE: Balloon Aortic Valvuloplasty in 2016 Equipment, Optimal Procedural Techniques, and Clinical Outcomes

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

A-fib Post-TAVR Associated With Increased Risk of Mortality, Bleeding

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

Post-TAVR Myocardial Injury Linked to Mortality

Medeon Biodesign Announces Successful First-in-man Studies for Large Bore Vascular Closure Device

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

A-fib, Whether Preexisting or New-Onset, Tied to Poor Outcomes in TAVR

Chronic Pacing Linked to Lower Survival After Balloon-Expandable TAVR

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Essential Medical Inc. Announces Successful Commencement of EU Studies for MANTA™ Large Bore Vascular Closure Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content